NEOGEN - Neogen Chemicals Limited Share Price

In the Q4 FY26 earnings call, Neogen Chemicals' management provided an optimistic outlook for FY27, anticipating standalone revenues between INR 875 crore and INR 950 crore. This revenue projection takes into account the expected full production from the Dahej replacement plant and other operational efficiencies. The management highlighted that the revenue guidance excludes contributions from the electrolyte salt and lithium electrolyte segments, which they expect to exceed INR 300 crore, primarily in the latter half of FY27.

Key strategic points include:

• The company's revenue for Q4 FY26 reached INR 247 crore, marking a 22% year-on-year growth, with EBITDA at INR 44 crore and an EBITDA margin of 17.8%. The profit after tax for the quarter was INR 11 crore.
• Neogen's focus remains on expanding its battery chemical segment, as indicated by a promoter group capital infusion of INR 161 crore to support growth in lithium-ion battery materials.
• The company is on track to commission both its Dahej and Pakhajan facilities within FY27, with expected completion costs for Dahej Phase 1 at INR 428 crore and Pakhajan Phase 2 at INR 1,367 crore.
• Significant customer demand is anticipated, along with improving visibility in the battery manufacturing ecosystem in India, reinforcing Neogen's position in the market.
• Management expects to achieve 18% to 20% return on capital employed (ROCE) for the battery projects after accounting for increased capital expenditures.

Overall, the management conveyed confidence in Neogen's strategic direction and market positioning amidst ongoing challenges in the global chemical industry.

Here are the major questions and their detailed answers from the Q&A section of the earnings transcript:

1. Question: "Can you tell us how much saving we can do or the returns that you expect? Are you increasing your ROCE as you mentioned in earlier discussion that 18% kind of returns you expect from this project?"

   Answer: "We are realigning our technology to Morita technology and adding a 500 metric ton intermediate facility for international sales. With operational efficiencies, our ROCE remains at 18% to 20%. The returns maintain this range despite the increased capex."

2. Question: "How much was the revenue from the electrolyte business in FY26?"

   Answer: "For FY26, the total revenue was INR 36 crore from Neogen Ionics, with the electrolytes contributing below INR 10 crore, mainly from salt sales."

3. Question: "When you are guiding INR 875 crore to INR 950 crore of revenue in FY27, how much revenue are you factoring in from salt plus electrolyte?"

   Answer: "The INR 875 crore to INR 950 crore guidance excludes any revenue from salt or electrolyte. It reflects a non-battery business outlook, including expected performance post-Dahej plant commissioning."

4. Question: "What is the status of lithium and bromine prices compared to the previous quarter?"

   Answer: "Bromine prices have stabilized due to resumed shipments. Lithium prices recently jumped but are now volatile, driven by demand for ESS and EVs. Predicting future fluctuations is challenging, but I consider current levels closer to long-term norms."

5. Question: "With increased CAPEX, what will be the peak debt?"

   Answer: "Our peak debt remains unchanged at INR 1,700 crore. The additional INR 160 crore from equity and $20 million from our JV partner cover expected costs, maintaining our financial stability without needing further debt."

6. Question: "What explains the increase in trade payables?"

   Answer: "The rise is due to negotiated longer credit terms with suppliers amidst financing needs. This arrangement is part of maintaining working capital efficiency while addressing short-term liquidity challenges."

7. Question: "What portion of electrolyte demand can we meet from our domestic giga factory customer scaling up to 2.5 gigawatts?"

   Answer: "We can meet 100% of their requirements with our existing capacity. There's a strong likelihood of fulfilling their needs efficiently, given our established relationship and past performance."

8. Question: "What does the timeline for the Pakhajan project entail?"

   Answer: "We expect to complete major electrolyte work by H1 FY27 and salt production by H2. The revised timeline aims for full operational capacity, ensuring robust revenue generation."

By consolidating these questions and answers, it becomes clear how Neogen Chemicals is navigating current market conditions and positioning itself for future growth.